Trade Journal

the latest financial results look great the com is sustain leader in e-commerce in south east asia and monee is providing additional high growth. i believe this is good risk reward growth stock for holding next several years

add more

add more

stock fail to go up

stalwart stock with 4% dividend pe 10 roe 20% net profit margin 17% and sitll grow with single digit with strong branding and balance sheet. this totally wort for investing. but the com just have Thai aging society risk which can reduce real estate market in thailand but the com grow internationally at 20% rate. I think it still has potential to maintain profit or grow a little.

sell more

business performance doesn't seem to be able to turn around, and dr give dividend much lesser than the real stock

company has real competitive moat against others and EV ESS market still have so much room to grow. even the price is quite high I believe it's investmentable since the com is really a quality com and right now give short term positive signal

add more

add more

add more

same reason as selling dr

business is uncertainty. it's better to see upcoming financial results before investment.

add more

hedging gold for de-dollarization trend

add more

add more

stop investing in too early stage business

divergence week rsi but macd day is about to cross down, so, i'll keep adding more position a little more

stock is dropped from ram price increasing and it is a short time event. the com is still have strong iot ecosystem and new ev business still performance really well. the price will be re rated after situation get back to normal.

add more

the global quality business with pe 6 is obviously undervalued and the company has still potential to grow

stop investing in early stage business

stop investing in early stage business

stop investing in early stage business

have better investment choices

after reconsideration this might not be the good time for investing in early stage business since there are many undervalued quality business with lower risk to invest

company that's growing consistently with pe 6 is crazy. the com is also in travel industry which still has future potential growth. strong branding. good balance. even the company gives guidance at 8% growth rate, it's still a good company to invest.

turnaround bet. the pharmaceutical leader with pe 10 doesn't make sense at all. financial results and technical signal give positive sign for turning around. this position also diversified portfolio from china

sell for buying other undervalued stocks

add more

now china give better investment choice in a long run

want change to invest in cha because it give better risk reward ratio

add more

add more

add more

this position is too risky so i think i need to hold it smaller

Instagram reels grow significantly, and new meta AI model muse spark 1.1 is now competitive. com pe 20 with 20% recent growth is reasonable. I think if meta can utilize their AI with ecosystem good enough the company can grow even further. although capex is really large and it is the thing that need to be concerned.

there is stock that can give more return

com just make profit in recent year and keep growing consistently with double digits. it's still early stage and has potential to grow heavily. I believe this stock is the one of coms that can capture biotech value.

binary biotech bet. company is in very early stage, so it can give high return if it succeed. balance sheet is ok and com also has deal with big pharma firm which is a positive sign

China has competitive advantage on biotech CDMO. this com has consistent growth with strong balance sheet. I believe it can capture value of biotech industry. I have strong conviction on biotech growth but china still has geopolitics risk to be monitored.

buy more on conviction

add more

add more

positive technical signal

want buy stock

thailand wellness has potential growth. Com also has strong branding and sssg is still growing consistently. the nature of this business can generate recurring income since customer need to maintain their skin. pe 15 with 5% dividend is a great valuation for investing.

the price doesn't go down and having buy pressure

after reconsideration, I think this position isn't a good investment decision at all

there's a chance hsi keep going down significantly

moonshot bet biotech

biotech bet

add more size for high conviction

have stock to invest

want buy stocks

good risk reward ratio. the company show sign of turnaround. sssg has increased but it's still negative. need to monitor and waiting for next financial results.

long term investment in robotic and i believe china has competitive advantage on this field.

add more

sell on technical signal

BBIK is still the potential growth company, which has only pe 10, is quite obviously undervalued. I also believe that AI will not disrupt company but enhance company performance instead. Technical also show positive sign.

add more

unsure about the market, so, i decide to use defensive strategy

sizing too small

technical is unclear right now.

add more

the price direction is unclear and it likely fall even further. sell position out and hold cash for better timing might be a better option

sizing is too small for high conviction

US market now is uncertainty to hold growth stocks

expiry date is to short for holding

cut loss. I should have sold it when I saw the oversold RSI already.

technical is turned to downside signal

bearish signal appear, with overbought in every timeframe

technical change. candlestick week isn't bullish signal anymore, so, cut loss is better

spx give bearish signal and MU RSI is overbought in week to year, with day macd is about to cross down.

technical is turned to downside signal

bearish signal on us market

bearish signal on us market

sell signal

snow sell pressure weakened

technical give bullish signal

technical give bullish signal

want to focus money on ntla

add more since technical clearly confirm

shortterm hedge snow

shortime selling for avoiding sell pressure

tencent buy side is strong no need to hedge

buy pressure weakened. sell for buying lower price

arrange cash for buying snow at lower price

add more because i think sizing is too small for this good risk reward ratio stock

add more

has better investment choice

another agentic ai theme with lower valuation. the company will benefit from user active on client platform, and new product Atlas is the new tailwind growth from agentic ai, which now perform well. I believe the new AI website will grow and they need to use database too. there is also room for many enterprise to convert their database to atlas instead of using conventional one.

use remain money for potential growth stock with good valuation. its business grow from asian side, so, portfolio is diversified

want to use remain money, and this com is also a good bet with agentic ai theme too. the ai can indirectly generate user for the platform, but the com has huge competition with github. however, i still believe this com has it own market.

add more

add more

wait for next financial results

week buy side and hold money for snow

hold cash for buying snow

set at peak rsi. too risky for holding with margin

adjust position size

the lastest earning call confirm my thesis, so, long term investment is valid now

holding cash for buying opportunity

long term cspr bet

waiting for latest earning's out, and need to rethink about investment strategy in growth stocks

q3 overall doesn't seem great in long term since company expect to grow only 20%

no need to hedge trip anymore

speculative thai fund flow

add more portion

AI agents, employees, apps, and cloud systems will all need secure access to company tools and data. As companies use more AI, they need to control who or what can access each app.

I believe that Angentic AI increase importance of enterprise data platform overtime. For AI agents to be useful inside companies, they need access to trusted, governed, auditable, and permissioned enterprise data. Snowflake has the potential to evolve from a cloud data warehouse into an AI Data Cloud where enterprises run analytics, AI workloads, and agentic applications on their internal data.

move to ZS

divergence on month RSI and MACD week is crossing up, with bullish candle stick on quarter time frame

long term biotech bet

speculative. month MA and quater macd are crossing up. year candle stick form a green doji

Defensive diversify, with spotting fund flow in SETHD. RATCH also has divergent on RSI month.

no longer need to hedge alibaba

add more

having high dividend and there is a buying signal. set also give positive sign of uptrend.

cut loss. holding cash waiting for lower price is better right now

trim position out because fund flow out of HSI significantly. waiting for the right timing to invest again

re-invest bbik dividend in kbank

trim position out because stock lose buying volume. waiting for price drop and buying tencent might be better

hedge Alibaba . currently spot sell signal

sell side lose momentum

same reason as previous trade

there is more potential investment, so, trim this stocks out is better

same reason as before

hedge tencent

RSI is overbought at every timeframe. Candlestick day show bearish signal. this company is cyclical too while people think it's a growth com. the stock will be de-rated when supply form other companies rise and fill the demand

speculative. fund flow is coming in Thai stock and Amata RSI isn't overbought yet.

cut loss. technical told that it will drop deeper

cut loss because technical view told that i will drop significantly

add more portion. the lastest report show positive on AI growth

hedge trip

add more stocks

thesis change. twist doesn't has moat as I thought. it could take over by new enzymatic synthesis

price is too high. rsi overbought, with red candle

add more portion

Speculative AI theme. with month MACD are about to cross up and RSI haven't been yet overbought. Company has a good narrative with large financing ang investing.

add more

buy as dr for tax reason

Alibaba has full ecosystem of cloud like google but is traded in lower PE. Qwen, Alibaba's LLM, is also popular in local use case which will affect positively to the brand. it show the potential growth with current pe is reasonable, with 1% dividend is attractive.

buy more for dividend

the company mainly do medicine development by using AI, which is the field that I believe that is a high growth industry. the company also partner with Eli Lilly

moonshot bet on CRISPR technology. this company focus on in-vivo crispr which has potential monetization and expanding.

investing in the believe that biotech will be the next high growth industry because of AI stimulation. The company is an essential infrastructure for all Biotech companies, like Nvidia in AI industry. If biotech is the next high growth industry, this stock will make a high ROI too.

AI bet but still be aware of tech bubble.

want to invest in Xiaomi without foreign taxes

The company has growth gradually. Now PE is only 13, which is a great price to buy because there will be demand form overwhelming data centers growth, and relocation supply chains from China. The company also pays dividend at 4-5%. There is still Vietnam growth risk that might take the market share.

Company is a digital consult company that have grow significantly, but the price stock went down because latest net come just grow slightly because of war and tariff. I believe that this are just short term drawbacks for the company, and digital industry still has a huge room to expand. the stock price is now at PE 10 which is the valuation of matured company. that doesn't make sense at all. However, AI is a new risk that might disrupt the company. imo, Thailand won't be able to catch up new technologies, and consults are still demanded

due to the war, make oil prices and oil demand increases, which will also generate demand on offshore service business of this company. Further more, BDI index has increased gradually, which is likely in an uptrend. It is the crucial factor that tells about the future company revenue growth, but the stock is still at the bottom. I also see the technical indicator, Bollinger squeeze, cross up MA/MACD, low RSI, which are buy signals.

Buying for dividend. has PTT, KTB as shareholders. insurance is also strong defensive business, even if, net income might be fluctuating but avg dividend pay is acceptable. which is about 7% and Thai people have gained financial literacy gradually. I believe that insurance industry will slowly grow too, which will affect the future dividend.

wanna invest in Tencent stock but don't want to pay foreign tax

buying for dividend reason. the company business is quite stable because of receiving concession. the return of dividend is about 6% which is at the acceptable level.

CHA price has been gradually decreased and now PE is 8, PS 1.11, and PB 1.94. This valuation is too low for its potential outside china growth. The brand is also unique and strong. last year, the company invested so much which can be spotted in CFI and CFF, thus, it's a sign for positive future outcomes.

Trip.com price has dropped for the reason that they are excused for monopoly. Now, PE 7.6, PS 3.8 PB 1.39. The valuation is too low for the fact that this company is the third largest travel agency platform in the world, and the growth of this industry in both China and the world. Balance sheet is also strong that has low debt which means they can potentially finance more money for investing, comparing to Booking holding which has more debt than thier assets. However, there are still government risk, which may affect the future profit margin, and AI risk, which might create the way to disrupt the platform, to be concerned. I still believe that the company will eventually pass through these obstacles.

The company ecosystem is so strong. I have conviction of their future growth from EV car and the narrative of Iot ecosystem that all their products connect together. The company have proved its effective development ability that can make different fields of products at high quality and lower cost. I believe that the company have much more potential to grow even in the situation of facing risen material cost of their phone sector.

Competitive moat from WeChat with Forward PE 13.6. The company dominate game industry, which, in the future, will gain advantages a lot from AI in the part of cost reduction. holding as a compounding stock is the best option. AI will also enhance potentially all their businesses too.